Gao Y - Search Results

1

Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.

Liu X, Gao Y, Shen J, Yang W, Choy E, Mankin H, Hornicek FJ, Duan Z. Liu X, et al. Among authors: gao y. Mol Cancer Ther. 2016 Jul;15(7):1691-701. doi: 10.1158/1535-7163.MCT-16-0032. Epub 2016 May 20. Mol Cancer Ther. 2016. PMID: 27207777 Free PMC article.

2

NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.

Yang X, Feng Y, Gao Y, Shen J, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: gao y. Gynecol Oncol. 2015 Apr;137(1):134-42. doi: 10.1016/j.ygyno.2015.02.002. Epub 2015 Feb 10. Gynecol Oncol. 2015. PMID: 25677062

3

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z. Gao Y, et al. Oncotarget. 2015 Apr 20;6(11):9313-26. doi: 10.18632/oncotarget.3220. Oncotarget. 2015. PMID: 25823654 Free PMC article.

4

Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.

Yang X, Shen J, Gao Y, Feng Y, Guan Y, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: gao y. Int J Cancer. 2015 Oct 15;137(8):2029-39. doi: 10.1002/ijc.29574. Epub 2015 May 5. Int J Cancer. 2015. PMID: 25904021 Free PMC article.

5

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.

Gao Y, Feng Y, Shen JK, Lin M, Choy E, Cote GM, Harmon DC, Mankin HJ, Hornicek FJ, Duan Z. Gao Y, et al. Sci Rep. 2015 Jun 16;5:11365. doi: 10.1038/srep11365. Sci Rep. 2015. PMID: 26079799 Free PMC article.

6

NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function.

Ye S, Zhang J, Shen J, Gao Y, Li Y, Choy E, Cote G, Harmon D, Mankin H, Gray NS, Hornicek FJ, Duan Z. Ye S, et al. Among authors: gao y. Br J Pharmacol. 2016 Feb;173(3):613-26. doi: 10.1111/bph.13395. Epub 2016 Jan 15. Br J Pharmacol. 2016. PMID: 26603906 Free PMC article.

7

Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro.

Shen JK, Cote GM, Gao Y, Choy E, Mankin HJ, Hornicek FJ, Duan Z. Shen JK, et al. Among authors: gao y. Sci Rep. 2016 Apr 29;6:25239. doi: 10.1038/srep25239. Sci Rep. 2016. PMID: 27125524 Free PMC article.

8

miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.

Duan Z, Gao Y, Shen J, Choy E, Cote G, Harmon D, Bernstein K, Lozano-Calderon S, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: gao y. Mol Oncol. 2017 Feb;11(2):151-166. doi: 10.1002/1878-0261.12015. Epub 2016 Oct 24. Mol Oncol. 2017. PMID: 28145098 Free PMC article. Clinical Trial.

9

Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.

Gao Y, Shen J, Choy E, Mankin H, Hornicek F, Duan Z. Gao Y, et al. Cell Oncol (Dordr). 2017 Jun;40(3):209-218. doi: 10.1007/s13402-017-0316-x. Epub 2017 Feb 27. Cell Oncol (Dordr). 2017. PMID: 28243976

10

Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Liao Y, Sassi S, Halvorsen S, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z. Liao Y, et al. Among authors: gao y. Sci Rep. 2017 Mar 6;7:43941. doi: 10.1038/srep43941. Sci Rep. 2017. PMID: 28262798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,152 results

Search Page

Filters